A randomized controlled trial comparing a digitally delivered gut-directed hypnotherapy (GDH) program (Nerva) to an active control found that GDH significantly improved IBS symptoms and quality of life. Among 240 participants, 81% of those using the GDH program experienced a ≥50-point decrease in IBS symptom severity compared to 63% in the control group (P = 0.002). GDH also led to a greater reduction in pain (71% vs. 35%, P < 0.001) and quality-of-life improvements (P < 0.001). These findings support digital GDH as an effective and accessible alternative to in-person behavioral interventions for IBS management.
Trending
- SPY001, An Anti-α4β7, Shows Promise in Phase 2 SKYLINE Trial for Ulcerative Colitis (HCP Live)
- Recognizing and Treating Iron Deficiency Anemia in Gastrointestinal Disorders (GI & Endoscopy News)
- GLP-1s carry ‘far higher’ than expected risk for residual gastric content during endoscopy (Healio)
- Why GI is at the center of innovation — and what’s holding back the specialty (Becker’s GI & Endoscopy)
- AI remains lacking in clinical reasoning abilities, according to study of 21 large language models (Medical Xpress)
- The top 10 regulatory burdens for medical practices in 2026 (Physicians Practice)
- ctDNA Blood Tests in Colorectal Cancer Screening: High Specificity, Limited Detection of Precancerous Lesions (Healthcare in Europe)
- The Magnetic Flexible Endoscope: Phase 1 First-in-Human Clinical Trial (The American Journal of Gastroenterology)
